Precipio, Inc.
$24.06-2.51%($-0.62)
TickerSpark Score
67/100
64
Valuation
35
Profitability
100
Growth
76
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRPO research report →
52-Week Range61% of range
Low $8.78
Current $24.06
High $33.63
Companywww.precipiodx.com
Precipio, Inc. , a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
- CEO
- Ilan Danieli
- IPO
- 2017
- Employees
- 54
- HQ
- New Haven, CT, US
Price Chart
+167.93% · this period
Valuation
- Market Cap
- $43.00M
- P/E
- -46.53
- P/S
- 1.65
- P/B
- 3.03
- EV/EBITDA
- 47.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 43.27%
- Op Margin
- -6.79%
- Net Margin
- -3.53%
- ROE
- -6.73%
- ROIC
- -10.03%
Growth & Income
- Revenue
- $24.05M · 50.64%
- Net Income
- $-363,000 · 91.54%
- EPS
- $-0.23 · 92.15%
- Op Income
- $-1,202,000
- FCF YoY
- 66.20%
Performance & Tape
- 52W High
- $33.63
- 52W Low
- $8.78
- 50D MA
- $27.95
- 200D MA
- $22.72
- Beta
- 1.38
- Avg Volume
- 30.76K
Get TickerSpark's AI analysis on PRPO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 15, 26 | Valauri Christina Rizopoulos | other | 93 |
| Apr 15, 26 | Cossman Jeffrey | other | 365 |
| Apr 15, 26 | Cohen David Seth | other | 445 |
| Apr 1, 26 | Sabet Ahmed Zaki | buy | 19 |
| Oct 15, 25 | ANDREWS RONALD ASBURY | other | 568 |
| Oct 15, 25 | Cohen David Seth | other | 746 |
| Oct 15, 25 | Cossman Jeffrey | other | 597 |
| Jan 2, 26 | Sabet Ahmed Zaki | buy | 20 |
| Oct 1, 25 | Sabet Ahmed Zaki | buy | 25 |
| Jul 8, 25 | Sabet Ahmed Zaki | buy | 31 |
Our PRPO Coverage
We haven't published any research on PRPO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PRPO Report →Similar Companies
LDDD+0.00%
Longduoduo Company Limited
$0.51
APUS-2.11%
Apimeds Pharmaceuticals US, Inc
$1.39
MODD+18.62%
Modular Medical, Inc.
$3.95
RBOT+4.76%
Vicarious Surgical Inc.
$0.88
PLUR+3.17%
Pluri Inc.
$2.60
MLSS+14.99%
Milestone Scientific Inc.
$0.40
POCI+0.40%
Precision Optics Corporation, Inc.
$5.04
STRR+3.86%
Star Equity Holdings, Inc.
$10.50